Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg |
PAX2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1362 | MERTK Blocking Peptide (AC1362) | 250 µg |
MERTK Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1363 | Presenilin 1 Blocking Peptide (AC1363) | 250 µg |
Presenilin 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1364 | Estrogen Receptor alpha Blocking Peptide (AC1364) | 250 µg |
Estrogen Receptor alpha Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1365 | Progesterone Receptor Blocking Peptide (AC1365) | 250 µg |
Progesterone Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg |
Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1367 | Myocilin Blocking Peptide (AC1367) | 250 µg |
Myocilin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg |
KCNJ2 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg |
Parkin Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1370 | EFEMP1 Blocking Peptide (AC1370) | 250 µg |
EFEMP1 Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1371 | Ki67 Blocking Peptide (AC1371) | 250 µg |
Ki67 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1372 | Exendin 4 (AC1372) | 20 µg |
Exendin-4 Recombinant
|
inquiry |
| ACPP-1373 | Human Interleukin 6 (Active) Protein (AC1373) | 10 µg |
Human Interleukin 6 (Active)
|
inquiry |
| ACPP-1374 | Human Ephrin A4 Protein (AC1374) | 2 µg |
Ephrin A4 Human Recombinant
|
inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg |
GABA(A) Receptor-Associated Protein Like 1 Human Recombinant
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.